Comprehensive Analysis of the Cardiac Resynchronization Therapy Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the cardiac resynchronization therapy market right now?
The cardiac resynchronization therapy market has seen strong growth in recent years. It will increase from $6.29 billion in 2024 to $6.74 billion in 2025, at a compound annual growth rate (CAGR) of 7.2%. This growth is driven by the aging population, an increase in heart failure cases, growing investments in R&D for CRT devices, and increased awareness of the therapy’s benefits, alongside physician training initiatives.
How fast Is the cardiac resynchronization therapy market expected to grow, and what’s its future value?
The cardiac resynchronization therapy market is expected to grow to $8.77 billion by 2029, with a CAGR of 6.8%. This growth is driven by the increasing prevalence of heart failure, a growing geriatric population, rising cardiovascular diseases, CRT therapy needs, and improvements in pacemaker and defibrillator treatments. Key trends include the adoption of CRT-D devices, advanced technology integration, expanded CRT therapy, AI adoption, and machine learning use.
Get your cardiac resynchronization therapy market report here!
What are the leading drivers of growth in the cardiac resynchronization therapy market?
The increasing prevalence of cardiovascular diseases is expected to boost the cardiac resynchronization therapy market. Factors such as aging, unhealthy lifestyles, and poor diets are contributing to a rise in cardiovascular diseases. Cardiac resynchronization therapy (CRT) improves the heart’s function by coordinating its contractions with synchronized electrical impulses. The Minnesota Department of Health reported in September 2024 that a significant portion of adults in the state have high blood pressure, leading to a greater need for CRT. Therefore, the increasing prevalence of cardiovascular diseases is pushing the growth of the CRT market.
What are the key segments defining the cardiac resynchronization therapy market?
The cardiac resynchronization therapy market covered in this report is segmented –
1) By Type: Cardiac Resynchronization Therapy (CRT)-Defibrillator, Cardiac Resynchronization Therapy (CRT)-Pacemaker
2) By Age: Below 44 Years, 45-64 Years, 65-84 Years, Above 85 Years
3) By End-Use: Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers
Subsegments:
1) By Cardiac Resynchronization Therapy (CRT)-Defibrillator: Single-Chamber CRT-D, Dual-Chamber CRT-D, Triple-Chamber CRT-D, Bi-Ventricular CRT-D
2) By Cardiac Resynchronization Therapy (CRT)-Pacemaker: Single-Chamber CRT-P, Dual-Chamber CRT-P, Triple-Chamber CRT-P, Bi-Ventricular CRT-P
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15531&type=smp
Who are the key players steering the development of the cardiac resynchronization therapy market?
Major companies operating in the cardiac resynchronization therapy market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Biotronik SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Integer Holdings Corporation, Merit Medical Systems Inc., LivaNova PLC, MicroPort Scientific Corporation, Sorin Group, Berlin Heart GmbH, EBR Systems Inc., Corvia Medical Inc., Recor Medical, Jarvik Heart Inc., Cardiac Dimensions Inc., Farapulse Inc., Osypka Medical GmbH, Japan Medical Device Corporation, Imricor Medical Systems Inc., Vascular Dynamics Inc., Svelte Medical Systems, Aleva Neurotherapeutics, BioSig Technologies Inc.
What emerging trends are influencing the growth of the cardiac resynchronization therapy market?
Major companies in the cardiac resynchronization therapy market are developing implantable devices to improve heart failure treatment outcomes. These devices synchronize heart contractions to improve pumping efficiency. In February 2024, MicroPort Scientific Corporation introduced the GALI SonR CRT-D device, which automatically optimizes heart function weekly, even during activity. This device has shown to reduce heart failure hospitalization risk by 35%, improving patient safety and treatment outcomes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15531
Which regions are most influential in expanding the cardiac resynchronization therapy market?
North America was the largest region in the cardiac resynchronization therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac resynchronization therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024
Vitamin D Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report
Tumor Ablation Therapy Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
